Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27.7M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
13.6M
-
Shares change
-
+248K
-
Total reported value, excl. options
-
$113M
-
Value change
-
+$2.37M
-
Number of buys
-
40
-
Number of sells
-
-29
-
Price
-
$8.30
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q2 2025
83 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q2 2025.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.6M shares
of 27.7M outstanding shares and own 49.11% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4.08M shares), Solas Capital Management, LLC (2.23M shares), Rosalind Advisors, Inc. (2.05M shares), BlackRock, Inc. (1.23M shares), VANGUARD GROUP INC (967K shares), AIGH Capital Management LLC (452K shares), STATE STREET CORP (336K shares), GEODE CAPITAL MANAGEMENT, LLC (305K shares), HARBERT FUND ADVISORS, INC. (288K shares), and MORGAN STANLEY (254K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.